[Redacted]
974
0
0
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 974 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (974)
[Trial of device that is not approved or cleared by the U.S. FDA]
Role: lead
[Trial of device that is not approved or cleared by the U.S. FDA]
Role: lead
[Trial of device that is not approved or cleared by the U.S. FDA]
Role: lead
[Trial of device that is not approved or cleared by the U.S. FDA]
Role: lead
[Trial of device that is not approved or cleared by the U.S. FDA]
Role: lead
[Trial of device that is not approved or cleared by the U.S. FDA]
Role: lead
[Trial of device that is not approved or cleared by the U.S. FDA]
Role: lead
[Trial of device that is not approved or cleared by the U.S. FDA]
Role: lead
[Trial of device that is not approved or cleared by the U.S. FDA]
Role: lead
[Trial of device that is not approved or cleared by the U.S. FDA]
Role: lead
[Trial of device that is not approved or cleared by the U.S. FDA]
Role: lead
[Trial of device that is not approved or cleared by the U.S. FDA]
Role: lead
[Trial of device that is not approved or cleared by the U.S. FDA]
Role: lead
[Trial of device that is not approved or cleared by the U.S. FDA]
Role: lead
[Trial of device that is not approved or cleared by the U.S. FDA]
Role: lead
[Trial of device that is not approved or cleared by the U.S. FDA]
Role: lead
[Trial of device that is not approved or cleared by the U.S. FDA]
Role: lead
[Trial of device that is not approved or cleared by the U.S. FDA]
Role: lead
[Trial of device that is not approved or cleared by the U.S. FDA]
Role: lead
[Trial of device that is not approved or cleared by the U.S. FDA]
Role: lead